Pharmahungary Group
- CMO, CRO
- Biotech or pharma, therapeutic R&D
We are an innovative R&D company with two missions:
1. develop novel miRNA therapeutics (oligonucleotide drugs) for cardiovascular, oncology, and musculoskeletal diseases supported by AI-driven drug discovery tools
2. provide services globally focusing on in vivo models of cardiovascular, metabolic, renal, and inflammation diseases from cells to large animals. Unique service: small and large animal multicenter studies for myocardial infarction and heart failure.
Schedule a meeting with the Founder & CEO of Pharmahungary Group, a worldwide key opinion leader in the pharmacology of cardioprotection (seven times ‘highly cited’ researcher) to discuss collaboration and co-development opportunities.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}